🎗️ Oncology Papers

Scholarly works matching "oncology" in Crossref, sorted by the number of times other DOI-registered works cite them. Citation counts come from Crossref and are usually lower than Google Scholar figures.

575 top-cited papers indexed

FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer (FIRE-3): a randomised, open-label, phase 3 trial

Volker Heinemann, Ludwig Fischer von Weikersthal et al. (2014)

The Lancet Oncology

1.5K citesjournal articlePDF

Atezolizumab in combination with carboplatin plus nab-paclitaxel chemotherapy compared with chemotherapy alone as first-line treatment for metastatic non-squamous non-small-cell lung cancer (IMpower130): a multicentre, randomised, open-label, phase 3 trial

Howard West, Michael McCleod et al. (2019)

The Lancet Oncology

1.5K citesjournal articlePDF

Incidence Proportions of Brain Metastases in Patients Diagnosed (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance System

Jill S. Barnholtz-Sloan, Andrew E. Sloan et al. (2004)

Journal of Clinical Oncology

1.5K citesjournal articlePDF

Olaparib Monotherapy in Patients With Advanced Cancer and a Germline BRCA1/2 Mutation

Bella Kaufman, Ronnie Shapira-Frommer et al. (2015)

Journal of Clinical Oncology

1.5K citesjournal articlePDF

Future of Cancer Incidence in the United States: Burdens Upon an Aging, Changing Nation

Benjamin D. Smith, Grace L. Smith et al. (2009)

Journal of Clinical Oncology

1.5K citesjournal articlePDF

Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3

Howard I. Scher, Michael J. Morris et al. (2016)

Journal of Clinical Oncology

1.5K citesjournal articlePDF

Surgical pathologic spread patterns of endometrial cancer: A gynecologic oncology group study

William T. Creasman, C. Paul Morrow et al. (1987)

Cancer

1.4K citesjournal articlePDF

Gastric Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology

Jaffer A. Ajani, Thomas A. D’Amico et al. (2022)

Journal of the National Comprehensive Cancer Network

1.5K citesjournal articlePDF

An Intergroup Phase III Comparison of Standard Radiation Therapy and Two Schedules of Concurrent Chemoradiotherapy in Patients With Unresectable Squamous Cell Head and Neck Cancer

David J. Adelstein, Yi Li et al. (2003)

Journal of Clinical Oncology

1.5K citesjournal articlePDF

Nivolumab in metastatic urothelial carcinoma after platinum therapy (CheckMate 275): a multicentre, single-arm, phase 2 trial

Padmanee Sharma, Margitta Retz et al. (2017)

The Lancet Oncology

1.5K citesjournal articlePDF

CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2014–2018

Quinn T Ostrom, Gino Cioffi et al. (2021)

Neuro-Oncology

1.5K citesjournal articlePDF

Measurement of Residual Breast Cancer Burden to Predict Survival After Neoadjuvant Chemotherapy

W. Fraser Symmans, Florentia Peintinger et al. (2007)

Journal of Clinical Oncology

1.5K citesjournal articlePDF

A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study

Henry M Keys, James A Roberts et al. (2004)

Gynecologic Oncology

1.4K citesjournal articlePDF

Salvage Regimens With Autologous Transplantation for Relapsed Large B-Cell Lymphoma in the Rituximab Era

Christian Gisselbrecht, Bertram Glass et al. (2010)

Journal of Clinical Oncology

1.5K citesjournal articlePDF

MONARCH 2: Abemaciclib in Combination With Fulvestrant in Women With HR+/HER2− Advanced Breast Cancer Who Had Progressed While Receiving Endocrine Therapy

George W. Sledge, Masakazu Toi et al. (2017)

Journal of Clinical Oncology

1.5K citesjournal articlePDF